Evidence map›Paper›PMID 41000330›Full record

ArticleJournal of Alzheimer's disease reports

Regular monitoring of SARS-CoV-2 carriage and antibody levels against the virus helped maintain social interactions for Alzheimer's disease residents in a Belgian nursing home during the pandemic.

Amandine Tytgat, Anh Nguyet Diep, Florence Flamme, Marie-Cécile Dupas, Jean Artois, Martine Fory, Margaux Dandoy, Frédérique Damseaux, Mutien-Marie Garigliany, Daniel Desmecht and 13 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Amandine TytgatLaboratory of Cellular and Molecular Immunology, GIGA Institute, University of Liège, Liège, Belgium.ORCID https://orcid.org/0009-0007-2223-7892
Anh Nguyet DiepBiostatistics Unit - Public Health Department, University of Liège, Liège, Belgium.ORCID https://orcid.org/0000-0001-5134-3220
Florence Flamme"Maison Vesale", Brussels, Belgium.
Marie-Cécile DupasLaboratory of Spatial Epidemiology, Université libre de Bruxelles, Brussels, Belgium.
Jean ArtoisLaboratory of Spatial Epidemiology, Université libre de Bruxelles, Brussels, Belgium.
Martine Fory"Maison Vesale", Brussels, Belgium.
Margaux DandoyCovid-19 Platform, University of Liège, Liège, Belgium.
Frédérique DamseauxCovid-19 Platform, University of Liège, Liège, Belgium.
Mutien-Marie GariglianyLaboratory of Pathology, FARAH, University of Liège, Liège, Belgium.ORCID https://orcid.org/0000-0001-6096-5726
Daniel DesmechtLaboratory of Pathology, FARAH, University of Liège, Liège, Belgium.
Marie-Pierre HayetteLaboratory of Clinical Microbiology, University Hospital of Liège, Liège, Belgium.
Catherine SabatelLaboratory of Cellular and Molecular Immunology, GIGA Institute, University of Liège, Liège, Belgium.
Michaël Artisien"Maison Vesale", Brussels, Belgium.
Sophie BrasseurInstitut libre Marie Haps (HE Vinci), Brussels, Belgium.
Yves van LaethemDepartment of Infectiology, Saint-Pierre University Hospital, Université libre de Bruxelles, Brussels, Belgium.
Charlotte MartinDepartment of Infectiology, Saint-Pierre University Hospital, Université libre de Bruxelles, Brussels, Belgium.ORCID https://orcid.org/0000-0002-8995-6230
Clotilde ViséeDepartment of Infectious Disease, Centre Hospitalier Régional Mons-Hainaut/Groupe Jolimont, Mons, Belgium.
Anne-Catherine GérardEndocrino-Diabetology Research Unit, Centre Hospitalier Régional Mons-Hainaut/Groupe Jolimont, Mons, Belgium.
Anne-Françoise DonneauBiostatistics Unit - Public Health Department, University of Liège, Liège, Belgium.
Laurent GilletFaculty of Veterinary Medicine, University of Liège, Liège, Belgium.
Patricia Kirkove"Maison Vesale", Brussels, Belgium.
Fabrice BureauLaboratory of Cellular and Molecular Immunology, GIGA Institute, University of Liège, Liège, Belgium.
Laurence FiévezLaboratory of Cellular and Molecular Immunology, GIGA Institute, University of Liège, Liège, Belgium.ORCID https://orcid.org/0000-0001-9581-8195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: People suffering from Alzheimer's disease and related disorders (ADRD) were severely impacted by the COVID-19 pandemic, both physically and mentally. Objective: This one-year study aimed to implement a protocol for controlling the spread of SARS-CoV-2 in a Belgian nursing home hosting exclusively patients suffering from ADRD, while minimizing pandemic-associated constraints. Methods: After confirming the absence of positive cases in the nursing home and the development of a proper immunity against SARS-CoV-2, the staff members enrolled in the study were allowed to remove their mask. Then, a weekly non-invasive saliva RT-qPCR testing for SARS-CoV-2 detection was implemented to detect cases among the staff and residents. A monthly serological monitoring was set up to follow the levels of neutralizing and IgG antibodies against SARS-CoV-2. Results: Three waves of COVID-19 infection were observed and quickly contained thanks to an effective quarantine policy. We confirmed the stronger humoral response developed by people infected before primo-vaccination compared to naïve-vaccinated ones and the weaker immune response of elderly individuals compared to younger participants, a difference abolished by booster. In parallel, we showed that ADRD people were able to develop a similar humoral response to SARS-CoV-2 vaccination or infection to that of people of similar age not suffering from these diseases. Conclusions: We show that a strict protocol aimed at early case detection and anti-SARS-CoV-2 immunity follow-up has enabled ADRD residents from a Belgian nursing home to maintain social interactions thanks to the ability of study participants to remove masks, while minimizing the risk of infection.

Indexed as

Alzheimer's diseaseimmunitynursing homesalivary diagnostic testSARS-CoV-2

Identifiers

PMID41000330
PMCPMC12457773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.